SCHEMBL14043203

SCHEMBL14043203

Bc1cnn2c(NCc3ccc(C(=O)O)cc3)cc(C3CCN(C(=O)OCc4ccccc4)CC3)nc12

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TRPC3 Q13507 2/20 0.44
▸ TRPC7 Q9HCX4 2/20 0.44
▸ USP30 Q70CQ3 1/20 0.43
▸ GSK3B P49841 3/20 0.42
▸ GRIN2B Q13224 7/20 0.42
▸ CYP2D6 P10635 4/20 0.42
▸ CYP2C9 P11712 4/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ CHEK1 O14757 1/20 0.40
▸ CCNA2 P20248 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ CCNA1 P78396 1/20 0.40
▸ CYP2C19 P33261 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ ENPP2 Q13822 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953650 0.91 GSK3B (0.54) TRPC3TRPC7USP30GSK3BGRIN2B
SCHEMBL13304833 0.89 CA2 (0.52) TRPC3TRPC7USP30GSK3BGRIN2B
SCHEMBL13305198 0.89 GSK3B (0.56) TRPC3TRPC7GSK3BGRIN2BCYP2D6
SCHEMBL13305170 0.88 TRPC3 (0.43) TRPC3TRPC7USP30GSK3BGRIN2B
SCHEMBL13305093 0.84 TRPC3 (0.41) TRPC3TRPC7USP30GSK3BGRIN2B
SCHEMBL12954207 0.83 GSK3B (0.51) TRPC3TRPC7USP30GSK3BGRIN2B
SCHEMBL12953919 0.82 TRPC3 (0.53) TRPC3TRPC7USP30GRIN2BCYP2D6
SCHEMBL13305133 0.82 TRPC3 (0.53) TRPC3TRPC7USP30GRIN2BCYP2D6
SCHEMBL12953550 0.81 GSK3B (0.52) TRPC3TRPC7GSK3BGRIN2BCYP2D6
SCHEMBL12953476 0.81 GSK3B (0.52) TRPC3TRPC7GSK3BGRIN2BCYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130570-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
Send feedback